The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective validation of urine based FGFR screening by Uromonitor within the real-world clinicopathological register trial BRIDGister.
 
Ralph M. Wirtz
Employment - STRATIFYER Molecular Pathology
Leadership - STRATIFYER Molecular Pathology
Stock and Other Ownership Interests - STRATIFYER Molecular Pathology
Research Funding - Cepheid; Janssen; Qiagen
Patents, Royalties, Other Intellectual Property - Qiagen; STRATIFYER Molecular Pathology
 
Elke Veltrup
Employment - STRATIFYER Molecular Pathology
 
Hugo Prazeres
Employment - Euromonitor
 
Carolina Dias
No Relationships to Disclose
 
Roland Hake
No Relationships to Disclose
 
Sebastian Eidt
Stock and Other Ownership Interests - STRATIFYER Molecular Pathology
 
Joao Vinagre
No Relationships to Disclose
 
Jenny Roggisch
No Relationships to Disclose
 
Stefan Koch
No Relationships to Disclose
 
Thorsten Ecke
Research Funding - Qiagen
Patents, Royalties, Other Intellectual Property - Qiagen